ESR1 and breast carcinoma: Based on the findings of a clinical breast cancer gene expression signature associated with high 14-3-3ζ and with risk of recurrence, we undertook studies to examine the effect of perturbing 14-3-3ζ levels on gene regulations and phenotypic properties of ER-positive breast cancer cells.